LRRC37A4P: A Potential Drug Target for Various Diseases (G55073)

Target Name: LRRC37A4P

NCBI ID: G55073

LRRC37A4P

Other Name(s): leucine rich repeat containing 37 member A4, pseudogene | LRRC37A4 | Leucine rich repeat containing 37 member A4, pseudogene | LRRC37

LRRC37A4P: A Potential Drug Target for Various Diseases

The protein LRRC37A4P, also known as leucine rich repeat containing 37 member A4, pseudogene (LRRC37A4P), is a gene that is located on chromosome 12q34.2 in humans. It is a non-coding RNA molecule that contains a repeat of the amino acid leucine. LRRC37A4P is expressed in most tissues of the body and is highly conserved across different species.

Expression and function

LRRC37A4P is a highly conserved gene that is expressed in most tissues of the body. It is found in various tissues such as muscle, heart, brain, and testes. LRRC37A4P is also expressed in placenta, where it is involved in the development and maintenance of new fetuses.

LRRC37A4P has been shown to play a role in various biological processes. One of its functions is to regulate cell growth and differentiation. It has been shown to be involved in the regulation of cell proliferation and the process of cell differentiation, including the regulation of stem cell proliferation and the process of neurogenesis.

LRRC37A4P has also been shown to play a role in the regulation of gene expression. It has been shown to interact with various transcription factors, including NF-kappa-B, AP-1, and STAT3. These transcription factors are responsible for regulating the expression of genes that are involved in various biological processes, including inflammation, stress response, and development.

Drug targeting

LRRC37A4P is a potential drug target in the treatment of various diseases. One of the reasons for its potential as a drug target is its involvement in various biological processes that are associated with the development and progression of diseases. For example, LRRC37A4P is involved in the regulation of cell growth and differentiation, which is potentially relevant to the treatment of cancer.

LRRC37A4P has also been shown to play a role in the regulation of inflammation. It has been shown to be involved in the regulation of the immune response and the production of pro-inflammatory cytokines. This may make it a potential target for the treatment of autoimmune diseases.

LRRC37A4P has also been shown to play a role in the regulation of stress response. It has been shown to be involved in the regulation of the stress response and the regulation of cellular stress. This may make it a potential target for the treatment of stress-related diseases.

Conclusion

LRRC37A4P is a non-coding RNA molecule that is highly conserved across different species and is expressed in most tissues of the body. It has been shown to play a role in various biological processes, including the regulation of cell growth and differentiation, the regulation of gene expression, and the regulation of inflammation and stress response. As a result, LRRC37A4P is a potential drug target for the treatment of various diseases. Further research is needed to fully understand the role of LRRC37A4P in disease and to develop effective treatments.

Protein Name: Leucine Rich Repeat Containing 37 Member A4, Pseudogene

The "LRRC37A4P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LRRC37A4P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets